Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$17.8 - $25.65 $3.86 Million - $5.57 Million
217,000 New
217,000 $5.2 Million
Q2 2020

Aug 14, 2020

SELL
$39.26 - $52.73 $58,890 - $79,095
-1,500 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $6.49 Million - $9.61 Million
-205,000 Reduced 99.27%
1,500 $63,000
Q4 2019

Feb 14, 2020

BUY
$36.21 - $51.4 $235,365 - $334,100
6,500 Added 3.25%
206,500 $8.83 Million
Q1 2019

May 15, 2019

BUY
$16.17 - $27.38 $80,850 - $136,900
5,000 Added 2.56%
200,000 $5.37 Million
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $2.54 Million - $4.25 Million
195,000 New
195,000 $4.05 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.